Unknown

Dataset Information

0

Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with 111In-DANBIRT.


ABSTRACT: BACKGROUND:111In-DOTA-butylamino-NorBIRT (DANBIRT) is a novel radioligand which binds to Leukocyte Function-associated Antigen-1 (LFA-1), expressed on inflammatory cells. This study evaluated 111In-DANBIRT for the visualization of atherosclerotic plaque inflammation in mice. METHODS AND RESULTS:ApoE-/- mice, fed an atherogenic diet up to 20 weeks (n = 10), were imaged by SPECT/CT 3 hours post injection of 111In-DANBIRT (~ 200 pmol, ~ 40 MBq). Focal spots of 111In-DANBIRT were visible in the aortic arch of all animals, with an average Target-to-Background Ratio (TBR) of 1.7 ± 0.5. In vivo imaging results were validated by ex vivo SPECT/CT imaging, with a TBR up to 11.5 (range 2.6 to 11.5). Plaques, identified by Oil Red O lipid-staining on excised arteries, co-localized with 111In-DANBIRT uptake as determined by ex vivo autoradiography. Subsequent histological processing and in vitro autoradiography confirmed 111In-DANBIRT uptake at plaque areas containing CD68 expressing macrophages and LFA-1 expressing inflammatory cells. Ex vivo incubation of a human carotid endarterectomy specimen with 111In-DANBIRT (~ 950 nmol, ~ 190 MBq) for 2 hours showed heterogeneous plaque uptake on SPECT/CT, after which immunohistochemical analysis demonstrated co-localization of 111In-DANBIRT uptake and CD68 and LFA-1 expressing cells. CONCLUSIONS:Our results indicate the potential of radiolabeled DANBIRT as a relevant imaging radioligand for non-invasive evaluation of atherosclerotic inflammation.

SUBMITTER: Meester EJ 

PROVIDER: S-EPMC6775031 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Imaging of atherosclerosis, targeting LFA-1 on inflammatory cells with <sup>111</sup>In-DANBIRT.

Meester E J EJ   Krenning B J BJ   de Blois R H RH   Norenberg J P JP   de Jong M M   Bernsen M R MR   Van der Heiden K K  

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20180313 5


<h4>Background</h4><sup>111</sup>In-DOTA-butylamino-NorBIRT (DANBIRT) is a novel radioligand which binds to Leukocyte Function-associated Antigen-1 (LFA-1), expressed on inflammatory cells. This study evaluated <sup>111</sup>In-DANBIRT for the visualization of atherosclerotic plaque inflammation in mice.<h4>Methods and results</h4>ApoE<sup>-/-</sup> mice, fed an atherogenic diet up to 20 weeks (n = 10), were imaged by SPECT/CT 3 hours post injection of <sup>111</sup>In-DANBIRT (~ 200 pmol, ~ 40   ...[more]

Similar Datasets

| S-EPMC4110972 | biostudies-literature
| S-EPMC8032543 | biostudies-literature
| S-EPMC5996370 | biostudies-literature
| S-EPMC6257909 | biostudies-literature
| S-EPMC6830127 | biostudies-literature
| S-EPMC4212241 | biostudies-literature
| S-EPMC5025806 | biostudies-literature
| S-EPMC5088780 | biostudies-literature
| S-EPMC2912446 | biostudies-literature
| S-EPMC6971215 | biostudies-literature